Red Light Holland's natural psilocybin microdosing capsules developed from psilocybin truffles grown in the Company's farm in The Netherlands, have...
BOSTON, MA / ACCESSWIRE / November 13, 2023 / Whittier Street Health Center, a community health center with a mission...
Family-owned-and-operated company Nature's Answer knows how important it is for parents to give their children products that have the best...
HONG KONG, CHINA / ACCESSWIRE / November 13, 2023 / INNODIGYM is revolutionizing the fitness industry with a groundbreaking solution...
SANTA CLARA, CA / ACCESSWIRE / November 13, 2023 / Zeto, Inc., an innovative EEG brain monitoring company, is excited...
MONTREAL, QC / ACCESSWIRE / November 13, 2023 / Sunshine Biopharma Inc. (NASDAQ:SBFM) (the "Company"), a pharmaceutical company offering and...
VANCOUVER, BC / ACCESSWIRE / November 13, 2023 / Frequency Exchange Corp. ("Frequency Exchange" or the "Company") (TSXV:FREQ) pleased to...
JACKSONVILLE, FL / ACCESSWIRE / November 13, 2023 / LFTD Partners Inc. ("LFTD Partners" or the "Company") (OTCQB: LIFD), the...
Hospital medical equipment rental and service partner continues expansion to meet extraordinary demand from for on-demand access to equipment as...
New updates designed to advance practice efficiency and patient outcomesMALVERN, Pa., Nov. 13, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ:...
– FDA feedback indicates Company’s CMC plans are in alignment with FDA’s requirements and expectations towards a BLA – –...
“Strategy is important. EXECUTION is everything.” Miami, FL, Nov. 13, 2023 (GLOBE NEWSWIRE) -- Earth Science Tech, Inc. (OTC: ETST)...
NORCROSS, Ga., Nov. 13, 2023 (GLOBE NEWSWIRE) -- Galectin Therapeutics, Inc. (NASDAQ: GALT), the leading developer of therapeutics that target...
Southlake, Texas, Nov. 13, 2023 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (Nasdaq: HSCS; HSCSW) (“HeartSciences” or the “Company”),...
Cash and cash equivalents of approximately $11.5 million as of October 31, 2023 Special meeting of stockholders on November 16 seeking...
The V&V process is an additional key milestone toward regulatory submission and is required to continue the regulatory process with...
PASADENA, Calif., Nov. 13, 2023 (GLOBE NEWSWIRE) -- LIXTE Biotechnology Holdings, Inc. (“LIXTE” or the “Company”) (Nasdaq: LIXT and LIXTW),...
Study to assess efficacy and safety of CVN424 as a monotherapy in early-stage Parkinson’s disease BOSTON, Nov. 13, 2023 (GLOBE...
First Phase 3 study of TNX-103 in PH-HFpEF patients to start in 4Q 2023 (The LEVEL Study)FDA agreement that 6MWD...
– Announced topline results from Phase 2 Trial of ABP-450 (prabotulinumtoxinA) for the preventive treatment of episodic migraine that support...